RNA interference mediated inhibition of histone deacetylase (HDAC) gene expression using short interfering nucleic acid (siNA)

Details for Australian Patent Application No. 2006261653 (hide)

International Classifications

Event Publications

2 August 2007 Section 223 Application Allowed

Sirna Therapeutics, Inc. The time in which to claim the convention priority date has been extended to 01 Oct 2006. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

20 March 2008 Application Open to Public Inspection

Published as AU-A-2006261653

20 March 2008 PCT application entered the National Phase

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.